Characteristics | Maternal fT4 tertiles (pmol/L) | P-Value | ||
---|---|---|---|---|
12.00-15.33 (N = 1001) | 15.34–18.67 (N = 2711) | 18.68-22.00 (N = 1221) | ||
Age, years, mean (SD) | 33.20 (5.11) | 32.33 (5.13) | 31.61 (5.10) | <0.0001 |
Age group, n (%) | <0.0001 | |||
<35years | 598 (59.74) | 1797 (66.29) | 887 (72.65) | |
≥ 35years | 403 (40.26) | 914 (33.71) | 334 (27.35) | |
BMI, kg/m2, mean (SD) | 22.80 (2.80) | 22.11 (2.85) | 21.76 (2.95) | <0.0001 |
AMH, ng/ml, median (IQR) | 2.61 (1.25 to 4.41) | 2.86 (1.51 to 4.91) | 3.16 (1.73 to 5.39) | <0.0001 |
AFC, median (IQR) | 12 (7 to 16) | 13 (8 to 17) | 13 (9 to 18) | <0.0001 |
DOR, n/N (%) | 223/1001 (22.28) | 513/2711 (18.92) | 188/1221 (15.40) | 0.0002 |
TSH, mIU/L, median (IQR) | 2.27 (1.67 to 2.95) | 2.23 (1.64 to 2.96) | 2.13 (1.52 to 2.81) | 0.001 |
<2.5 mIU/L, n (%) | 597 (59.64) | 1633 (60.24) | 795 (65.11) | 0.007 |
≥ 2.5 mIU/L, n (%) | 404 (40.36) | 1078 (39.76) | 426 (34.89) | |
fT3, pmol/L, median (IQR) | 4.59 (4.23 to 4.90) | 4.79 (4.46 to 5.18) | 4.96 (4.59 to 5.37) | <0.0001 |
fT4, pmol/L, median (IQR) | 14.47 (13.75 to 14.97) | 16.96 (16.17 to 17.79) | 19.71 (19.13 to 20.62) | <0.0001 |
TAI, n (%) | 0.4513 | |||
Positive | 157 (15.68) | 381 (14.05) | 175 (14.33) | |
Negative | 844 (84.32) | 2330 (85.95) | 1046 (85.67) | |
Infertility type, n (%) | <0.0001 | |||
Primary | 366 (36.56) | 1156 (42.64) | 555 (45.45) | |
Secondary | 635 (63.44) | 1555 (57.36) | 666 (54.55) | |
Infertility diagnosis, n (%) | 0.0233 | |||
Tubal factor | 564 (56.34) | 1518 (55.99) | 703 (57.58) | |
Diminished ovarian reserve | 203 (20.28) | 470 (17.34) | 186 (15.23) | |
Male factor | 72 (7.19) | 249 (9.18) | 122 (9.99) | |
Unexplained | 33 (3.30) | 112 (4.13) | 60 (4.91) | |
Mixed factors | 129 (12.89) | 362 (13.35) | 150 (12.29) | |
Ovarian stimulation protocol, n (%) | 0.0023 | |||
Long protocol | 404 (40.97) | 1206 (45.00) | 579 (47.93) | |
Antagonist protocol | 369 (37.42) | 1016 (37.91) | 443 (36.67) | |
Mild stimulation protocol | 129 (13.08) | 259 (9.66) | 103 (8.53) | |
Other protocols | 84 (8.52) | 199 (7.43) | 83 (6.87) | |
No. of aspirated oocytes, meidian (IQR) | 9 (4 to 14) | 10 (5 to 15) | 11 (6 to 16) | <0.0001 |